Detalhe da pesquisa
1.
Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer.
Bioorg Chem
; 143: 107056, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183685
2.
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study.
BMC Cancer
; 23(1): 1239, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102538
3.
Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.
BMC Geriatr
; 22(1): 987, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539696
4.
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).
Bioorg Med Chem
; 26(18): 5006-5017, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150104
5.
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).
Bioorg Med Chem
; 26(22): 5974-5985, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30401501
6.
Jesridonin in combination with paclitaxel demonstrates synergistic anti-tumor activity in human esophageal carcinoma cells.
Bioorg Med Chem Lett
; 27(9): 2058-2062, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285918
7.
Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
Bioorg Med Chem Lett
; 25(5): 1124-8, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655718
8.
HER2+ advanced gastric cancer: Current state and opportunities (Review).
Int J Oncol
; 64(4)2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391024
9.
Roles and inhibitors of FAK in cancer: current advances and future directions.
Front Pharmacol
; 15: 1274209, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410129
10.
Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors.
Melanoma Res
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647119
11.
Degraders in epigenetic therapy: PROTACs and beyond.
Theranostics
; 14(4): 1464-1499, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389844
12.
Synthesis and clinical application of new drugs approved by FDA in 2022.
Mol Biomed
; 4(1): 26, 2023 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661221
13.
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study.
Technol Cancer Res Treat
; 22: 15330338221150561, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632666
14.
An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study.
Clin Colorectal Cancer
; 22(1): 76-84, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564281
15.
Oxazolidinone: A promising scaffold for the development of antibacterial drugs.
Eur J Med Chem
; 250: 115239, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893700
16.
Effects of Ecological Restoration and Climate Change on Herbaceous and Arboreal Phenology.
Plants (Basel)
; 12(22)2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38005811
17.
Application and synthesis of thiazole ring in clinically approved drugs.
Eur J Med Chem
; 250: 115172, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758304
18.
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.
Eur J Med Chem
; 258: 115606, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402343
19.
Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study.
Front Oncol
; 12: 917353, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226061
20.
Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma.
Front Immunol
; 13: 1010554, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275697